The diagnosis of Joe Biden’s cancer brings two controversial issues: PSA tests for prostate cancer and political politics. To find out what American Americans need the main information about the PSA test, and a straightforward reference to the rationalization of the prostate screening in the case of former president. The dribble of the information we got only made the most uncomfortable questions for biden and his family. The loss of adequate explanation has also failed to contribute to public appreciation for significant medical issues.
Prostate, a walnut-shaped gland at the base of the bladder, produces “prostate specified antigen,” or PSA. The chemical class as a glycoprotein, a sugar / protein that is united, it produces the prostate to the blood, where its blood level can measure the usual blood test.
As old men, prostate, add to PSA level. Screening tests take advantage of the fact that prostate cancer usually drips more than PSA than normal prostate tissue. And in case of prostate cancer, the average of PSA usually rises quite fast.
More than basic facts, the story of the PSA has become Hazy. Although a long PSA can be a signal cancer, most men with a high PSA have a prostate extension value, non-prostate cancer. Worse for screening, many men with prostate cancer have a gentle and slow movement without treatment. They join their illness instead of dying it. This fact leads the ancient proverb that prostate cancer is the pain of long-term Papa and Supreme Court in the Supreme Court.
Medical panels panels are viewing PSA screening with suspicion due to challenges to identify cancer highs. Confirmation of a suspected cancer cancer requires prostate biopsies to be painful and affording effects. In addition, once a diagnosis has been made, patients who may have experienced their illness may not necessarily be subjected to treatment damages, such as radiation and operation. Finally, the benefits of early prostate cancer treatment are difficult to prove clinical studies.
For all these reasons medical advisory panels have lost a large test or recommended a nuanced method with risks and doctors.
Despite these concerns, the pendulum began further testing PSA in recent years. A reason is that radiographic imaging developments, such as MRI, allowed for “active monitoring” to allow signs of spreading prostate cases and those who are likely to prosper. Interruptions can be directly instructed by those in high risk.
In my practice medicine, I am generally a contestant for prostate cancer screening despite the controversy surrounding clinical benefits. My experience brings me to believe that early diagnosis has developed prognosis. But even if there are no good medical consequences, patients and their families still benefit from early diagnosis for planning purposes. No one wants to catch a period of symptomatic stage limiting clinical and life options.
In Biden case, after some initial delay is a spokesman revealed on May 20 without a test of PSA since 2014, during Biden’s vice presidency. Reasons are not revealed.
Such a decision may be justified based on questions about PSA tests and risks. However, the importance of the health of a vice president and potential future president is the one who expects doctors to err with further information. Evaluation invites to estimate the political implications of a borderline or adding to PSA may have a decisive role. More information about his last PSA and the basis of the decision that does not continue to screening may be placed such a conjecture.
In the past, the public has gained insight to the important medical conditions from unfortunate diseases affected the first families. Cancer cancer screening receives additional attention after Diagnose President Reagan in 1985. Betty Ford’s Public expression of his struggles With alcoholism and prescription drug resolution helped with de-stigmatizing treatment for substance use disorders.
Biden’s disease also gives a chance. Imagine that prostate cancer imposes the greatest risk of cancer death facing non-smoked American men. The transparency of facing the condition of former President serves public interests by increasing awareness and understanding of important, nuanced decisions to take care of many people.
Daniel J. Stone is an internist and Geriatrician of Beverly Hills.
Insights
La Times Insights Gives AI-Ginaleans analysis of Venters in Voices to offer all points in view. Views cannot be found in any news articles.
view
Views
The following content becomes AI run by confusion. Los Angeles editorial staff do not create or edit content.
Ideas stated in the piece
- The article argues that the former Preserentatic Cancer cancer cancer cancer provides the public education about oversigenosis and hard work complexes.
- The author, a doctor, promotes PSA screening despite doubt of medical advistory panels, plans for potential consequences, even if clinical benefits cannot be reached.
- Lack of bid-testing since 2014 is criticized as a bad opportunity for transparency, with counting political considerations to avoid sconstruction of his vice president and potential presidential aspirations.
- The piece promotes examples of history, such as cancer cancer of Reagan and Betty Ford using the Ford S-substance, to indicate how public struggles make the public.
Different views of the subject
- Medical Advisory Panels Long Losses PSA Encouragement Due to the risks of false positives, not affecting the development of shores that may have wider doubt about the clinical value(2).
- Biden health reports from 2021 to 2024 have no signs of prostate review, which are the skinny ones that are targeted, the development of development of skin development(1).
- A Biden spokesman made his last PSA test occurred in 2014 and emphasized that he did not claim cancer information on May 2025, counters the restrictions and stagnation of the stagnation of patterns(2).
- The odd to the later stage of prostate cancer (8% of cases) highlights that metal biden disease is a general human pointing health compared to more common cases in the first stage(2).
